Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $500.00 | $6.67K | $3.33K | $1.00M | $625K | $248K | — | — | $6.00K |
| Revenue growth | — | — | 1233.4% | -50.0% | 29903.0% | -37.5% | -60.4% | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | $6.00K |
| Gross margin | — | — | — | — | — | — | — | — | — | 100.0% |
| Operating income | -$670K | -$534K | -$603K | -$558K | $613K | $224K | -$22.8K | -$116K | -$271K | -$13.1M |
| Operating margin | — | -106721.8% | -9045.4% | -16739.9% | 61.3% | 35.9% | -9.2% | — | — | -218426.8% |
| Net income | -$1.13M | -$837K | -$548K | -$884K | $358K | -$797K | -$768K | -$382K | -$528K | -$31.8M |
| Net margin | — | -167438.0% | -8214.8% | -26529.2% | 35.8% | -127.6% | -310.4% | — | — | -529472.1% |
| EPS (diluted) | -$0.05 | -$0.04 | -$0.03 | -$0.04 | $0.02 | $0.04 | $0.04 | -$0.02 | -$0.02 | -$1.23 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$635K | -$372K | -$420K | -$366K | -$218K | -$56.9K | $7.75K | -$123K | -$157K | -$257K |
| Capital expenditures | $9.98K | — | $4.17K | — | — | $9.50K | — | — | — | — |
| Free cash flow | -$645K | — | -$424K | — | — | -$66.4K | — | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $27.2K | $9.18K | $5.63K | $228K | $235K | $113K | $13.2K | $359K |
| Total assets | $955K | $121K | $315K | $237K | $1.27M | $1.01M | $429K | $221K | $95.6K | $398K |
| Total liabilities | — | $1.65M | $2.43M | $3.18M | $3.86M | $4.41M | $4.59M | $4.76M | $5.17M | $3.77M |
| Long-term debt | — | — | — | — | — | — | $480K | $491K | — | $25.0K |
| Shareholders' equity | $126K | -$1.52M | -$2.07M | -$2.89M | -$2.53M | -$3.39M | -$4.16M | -$4.54M | -$5.07M | -$3.38M |
| Retained earnings | -$1.51M | -$2.35M | -$2.82M | -$3.70M | -$3.34M | -$4.21M | -$4.97M | -$5.36M | -$5.88M | -$37.7M |
| Shares (wtd avg diluted) | 21.6M | 21.6M | 21.6M | 21.7M | 24.9M | 21.7M | 21.7M | 21.7M | 21.7M | 25.7M |
Every figure is extracted from Balance Labs, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.